Stock listing

Immupharma Plc

Selected listing: IMM · LSE · GBX · GB

Immupharma Plc (LSE:IMM), Health Technology. Latest release Sep 15, 2026: New peer-reviewed publication.

IMM:LSEGBXGBUpdated October 3, 2026

Ticker: LSE:IMM
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: LSE
Currency: GBX

About Immupharma Plc

The company focuses on developing innovative pharmaceutical products, particularly in the field of immunology. Immupharma aims to address unmet medical needs through its research and development efforts.

Latest news from Immupharma Plc

New peer-reviewed publication

September 15, 2026

Bioanalytical CRO partner for Kapiglucagon

August 10, 2026

Thermo Fisher CDMO selected for Kapiglucagon pro

July 22, 2026

2026 RESULT OF ANNUAL GENERAL MEETING

June 25, 2026

University of Murcia research relating to P140

June 24, 2026

All Immupharma Plc news →

Events

Replays

IMMUPHARMA PLC (IMM) — Corporate Update
Fri, Mar 20, 2026 · 08:00 AM ET
Watch
IMMUPHARMA PLC (IMM) — Investor Presentation
Thu, Aug 04, 2022 · 07:00 AM ET
Watch
IMMUPHARMA PLC (IMM) — Annual General Meeting
Mon, Jun 28, 2021 · 05:30 AM ET
Watch

Research Immupharma Plc

Immupharma Plc company profile

View the public company page for Immupharma Plc on 6ix.

Immupharma Plc news

Read company news and market updates connected to Immupharma Plc.

Immupharma Plc investor events

Find investor webinars, events, and replay context for Immupharma Plc.